These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

343 related items for PubMed ID: 20177102

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Imaging features of colorectal liver metastasis in FDG PET-CT: a retrospective correlative analysis between CT attenuation and FDG uptake.
    Au-Yeung AW, Luk WH, Lo AX.
    Nucl Med Commun; 2012 Apr; 33(4):403-7. PubMed ID: 22273638
    [Abstract] [Full Text] [Related]

  • 6. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT.
    Inglese E, Leva L, Matheoud R, Sacchetti G, Secco C, Gandolfo P, Brambilla M, Sambuceti G.
    J Nucl Med; 2007 Oct; 48(10):1662-9. PubMed ID: 17873124
    [Abstract] [Full Text] [Related]

  • 7. Altered hepatic metabolic activity in patients with hepatic steatosis on FDG PET/CT.
    Abikhzer G, Alabed YZ, Azoulay L, Assayag J, Rush C.
    AJR Am J Roentgenol; 2011 Jan; 196(1):176-80. PubMed ID: 21178064
    [Abstract] [Full Text] [Related]

  • 8. Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions.
    Okada M, Shimono T, Komeya Y, Ando R, Kagawa Y, Katsube T, Kuwabara M, Yagyu Y, Kumano S, Imaoka I, Tsuchiya N, Ashikaga R, Hosono M, Murakami T.
    Ann Nucl Med; 2009 Jun; 23(4):349-54. PubMed ID: 19340526
    [Abstract] [Full Text] [Related]

  • 9. Does multidetector CT attenuation change in colon cancer liver metastases treated with 90Y help predict metabolic activity at FDG PET?
    Tochetto SM, Rezai P, Rezvani M, Nikolaidis P, Berggruen S, Atassi B, Salem R, Yaghmai V.
    Radiology; 2010 Apr; 255(1):164-72. PubMed ID: 20308454
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Adrenal nodules at FDG PET/CT in patients known to have or suspected of having lung cancer: a proposal for an efficient diagnostic algorithm.
    Brady MJ, Thomas J, Wong TZ, Franklin KM, Ho LM, Paulson EK.
    Radiology; 2009 Feb; 250(2):523-30. PubMed ID: 19188319
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of Standardized Uptake Values in Normal Structures Between PET/CT and PET/MRI in a Tertiary Pediatric Hospital: A Prospective Study.
    Lyons K, Seghers V, Sorensen JI, Zhang W, Paldino MJ, Krishnamurthy R, Rohren EM.
    AJR Am J Roentgenol; 2015 Nov; 205(5):1094-101. PubMed ID: 26496558
    [Abstract] [Full Text] [Related]

  • 15. Adrenal masses in patients with cancer: PET/CT characterization with combined CT histogram and standardized uptake value PET analysis.
    Perri M, Erba P, Volterrani D, Guidoccio F, Lazzeri E, Caramella D, Mariani G.
    AJR Am J Roentgenol; 2011 Jul; 197(1):209-16. PubMed ID: 21701032
    [Abstract] [Full Text] [Related]

  • 16. Focal uptake of fluorodeoxyglucose by the thyroid in patients undergoing initial disease staging with combined PET/CT for non-small cell lung cancer.
    Yi JG, Marom EM, Munden RF, Truong MT, Macapinlac HA, Gladish GW, Sabloff BS, Podoloff DA.
    Radiology; 2005 Jul; 236(1):271-5. PubMed ID: 15987980
    [Abstract] [Full Text] [Related]

  • 17. Defining a radiotherapy target with positron emission tomography.
    Black QC, Grills IS, Kestin LL, Wong CY, Wong JW, Martinez AA, Yan D.
    Int J Radiat Oncol Biol Phys; 2004 Nov 15; 60(4):1272-82. PubMed ID: 15519800
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Variations of the hepatic SUV in relation to the body mass index in whole body PET-CT studies].
    Batallés SM, Villavicencio RL, Quaranta A, Burgos L, Trezzo S, Staffieri R, Pezzotto SM.
    Rev Esp Med Nucl Imagen Mol; 2013 Jan 15; 32(1):26-32. PubMed ID: 23177341
    [Abstract] [Full Text] [Related]

  • 20. Hepatic steatosis is associated with increased hepatic FDG uptake.
    Keramida G, Potts J, Bush J, Dizdarevic S, Peters AM.
    Eur J Radiol; 2014 May 15; 83(5):751-5. PubMed ID: 24581596
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.